SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?


To: Rande Is who wrote (29064)7/7/2000 9:22:33 AM
From: johnsto1  Read Replies (1) | Respond to of 57584
 
Orchid and PE Biosystems Establish
Licensing Agreement For Orchid's
SNP-IT(TM) Primer Extension
Technology

07/07/00

PRINCETON, N.J., July 7 /PRNewswire/ -- Orchid BioSciences, Inc. (Nasdaq:
ORCH) today announced that it has granted a non-exclusive license to PE
Biosystems (NYSE: PEB), a PE Corporation business, to use Orchid's
patented SNP-IT(TM) single base primer extension technology for single
nucleotide polymorphism (SNP) analysis in PE Biosystems' ABI PRISM(R)
reagent kits, including SNaPshot(TM) ddNTP Primer Extension kits. Under the
terms of the agreement, PE Biosystems will produce and market kits that are
licensed under U.S. patents 5,888,819 and 6,004,744, which are owned by
Orchid and cover Orchid's SNP-IT technology for performing SNP analyses.
Terms of the deal were not disclosed.



To: Rande Is who wrote (29064)7/7/2000 9:25:33 AM
From: Rande Is  Read Replies (4) | Respond to of 57584
 
On a stock we used to follow a while back. . . BVSN. . . lost a critical contract with American Airlines [AA.com] to ARTG. There seems to be question as to whether they can win the big ones.

09:13 ET BroadVision (BVSN) 53 5/8: -- Update -- Hearing from SG Cowen that there are reports company is having trouble implementing technology at key customers. Also there are concerns that organic growth is slowing some, something that Wall Street had not been prepared for... Stock trading at $45 in pre-market.

Heard rumor that ORCH CEO is on Power Lunch. . . need confirmation. ISLD 46 3/4 pre-market

Careful out there. . .

Rande Is